Fig. 7From: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulationGraphical model. Domatinostat by preventing nuclear translocation and down-modulating FOXM1 expression, targets cancer stem cell compartment thus sensitizing PDAC cells to gemcitabine/nab-paclitaxel treatmentBack to article page